1 study found for:    23077008 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size;   Ciliary Body and Choroid Melanoma, Small Size;   Iris Melanoma;   Metastatic Intraocular Melanoma;   Recurrent Intraocular Melanoma;   Stage IV Intraocular Melanoma
Interventions: Drug: selumetinib;   Drug: temozolomide;   Drug: dacarbazine;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment

Indicates status has not been verified in more than two years